Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions. by Elis, Ori et al.
Psychosocial treatments for negative symptoms in schizophrenia:
Current practices and future directions
Ori Elis 1, Janelle M. Caponigro ⁎,1, Ann M. Kring
Department of Psychology, University of California, Berkeley, USA
H I G H L I G H T S
• We review studies that report on negative symptom outcomes in schizophrenia.
• At best, psychosocial treatments show moderate improvements in negative symptoms.
• Cognitive behavior therapy and social skills training show the most promise.
• We identify future directions for the development of negative symptom interventions.
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Schizophrenia can be a chronic and debilitating psychiatric disorder. Though advancements have been made
in the psychosocial treatment of some symptoms of schizophrenia, people with schizophrenia often continue
to experience some level of symptoms, particularly negative symptoms, throughout their lives. Because
negative symptoms are associatedwith poor functioning and quality of life, the treatment of negative symptoms
is a high priority for intervention development. However, current psychosocial treatments primarily focus on
the reduction of positive symptoms with comparatively few studies investigating the efficacy of psychosocial
treatments for negative symptoms. In this article, we review and evaluate the existing literature on three
categories of psychosocial treatments — cognitive behavioral therapy (CBT), social skills training (SST),
and combined treatment interventions — and their impact on the negative symptoms of schizophrenia.
Of the interventions reviewed, CBT and SST appear to have the most empirical support, with some evidence
suggesting that CBT is associatedwithmaintenance of negative symptom improvement beyond sixmonths after
treatment. It remains unclear if a combined treatment approach provides improvements above and beyond
those associated with each individual treatment modality. Although psychosocial treatments show promise for
the treatment of negative symptoms, there are many unanswered questions about how best to intervene.
We conclude with a general discussion of these unanswered questions, future directions and methodological
considerations, and suggestions for the further development of negative symptom interventions.
© 2013 Elsevier Ltd. All rights reserved.
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1. Introduction
Schizophrenia can be a debilitating disorder that affects the way a
person thinks, feels, and behaves. The DSM-5 (American Psychiatric
Association, 2010) diagnostic criteria for schizophrenia include delu-
sions (e.g., beliefs not rooted in reality), hallucinations (e.g., sensory
experiences not rooted in reality), disorganized speech (e.g., incoher-
ent verbal communication), disorganized behavior or catatonia (e.g.,
inappropriate or unusual actions or movements), and negative symp-
toms (e.g., diminishedmotivation or behavior). At least one of the two
symptoms must include delusions, hallucinations, or disorganization,
and the symptoms must cause functional impairment and persist for
six months either in their “active phase” or in a more residual manner.
Consensus in the field suggests that there are five negative
symptoms: blunted affect, alogia, asociality, anhedonia, and avolition
(Kirkpatrick, Fenton, Carpenter, & Marder, 2006). These symptoms are
referred to as ‘negative’ because they involve an absence of or deficits
in experiences that are typically present in healthy people. Blunted af-
fect, or affective flattening, refers to decreased or restricted emotional
expression, including the range and intensity of facial, vocal, and non-
verbal expression. Alogia, or poverty of speech, is decreased verbal pro-
duction or fluency. Asociality involves decreased interest,motivation, or
desire to spend timewith others; it ismost easily identifiedbehaviorally
as a lack ofmeaningful relationshipswith friends or families. Anhedonia
is a decreased ability to experience pleasure from activities that are usu-
ally found enjoyable. Recent research points to an important distinction
between in-the-moment, or consummatory, pleasure (e.g., enjoying
a tasty slice of pizza) and anticipatory pleasure (e.g., anticipating a
delicious slice of pizza for lunch). In schizophrenia, it appears that
while consummatory pleasure remains intact, anticipating future
pleasurable experiences is problematic (Gard, Kring, Germans Gard,
Horan, & Green, 2007; Kring & Caponigro, 2010). Finally, avolition is a
deficit in the ability to initiate and persist in goal-directed behavior.
This symptom involves both the desire to pursue tasks and the ability
to follow through to completion.
Factor analytic studies have indicated that the five negative symp-
toms can be more parsimoniously explained by two factors: 1) dimin-
ished expression, including the symptoms of blunted affect and alogia;
and 2) diminished motivation and pleasure, including the symptoms
of avolition, anhedonia and asociality (Blanchard & Cohen, 2006;
Horan, Kring, Gur, Reise, & Blanchard, 2011; Kring, Gur, Blanchard,
Horan, & Reise, 2013). The DSM-5 description of negative symptoms
parallels this conceptualization, defining negative symptoms as being
composed of restricted affect and restricted avolition/asociality.
Approximately 15–20% of people with schizophrenia experience
negative symptoms that persist during periods of clinical stability and
remain untouched by current treatments (Buchanan, 2007). Further-
more, negative symptoms are associatedwith poor functional outcomes
(e.g., Herbener & Harrow, 2004; Milev, Ho, Arndt, & Andreasen, 2005).
Thus, interventions that are designed to treat negative symptoms are
of high priority since negative symptoms are strongly related to func-
tional outcomes and they have an independent effect on outcomes rel-
ative to other schizophrenia symptoms (Rabinowitz et al., 2012).
2. Current treatment recommendations for schizophrenia
Though advancements have been made in the treatment of
schizophrenia over the last decades, reducing the “revolving door”
of stabilization and re-hospitalization, people with schizophrenia
often experience residual symptoms, significantly affecting their
quality of life. Medications are used as the first line of treatment
to help reduce acute symptom exacerbation and as a maintenance
treatment in order to reduce the risk of relapse (Buchanan et al.,
2010). Unfortunately, pharmacological treatments have limited effects
on negative symptoms and may even contribute to or exacerbate
secondary negative symptoms (Buchanan et al., 2010; for a meta-
analysis, see Leucht et al., 2009).
Psychosocial interventions, as an adjunct treatment to medications,
are now a widely accepted treatment approach to help target areas of
impairment, providing additional relief from the distress of symptoms.
In fact, current treatment recommendations for schizophrenia from
the Patient Outcomes Research Team (PORT) specify medications plus
psychosocial interventions (Dixon et al., 2010). Current psychosocial
treatments for schizophrenia, however, have been mostly one-sided,
with treatments primarily targeting positive symptoms (i.e., delusions
or hallucinations). This is surprising given that the negative symptom
domains of diminished expression and motivation/pleasure have been
considered a central component of the illness dating back to when it
wasfirst described (Bleuler, 1950; Kraepelin, 1919). The only psychoso-
cial intervention included in the PORT recommendations for the treat-
ment of negative symptoms is cognitive behavioral therapy (CBT) and
as we review later, CBT intervention studies have yielded mixed
findings, with some showing improvements in negative symptoms
and others showing no change (Wykes, Steel, Everitt, & Tarrier,
2008). Although other interventions have shown promise for im-
proving negative symptoms, their efficacy is modest at best (Erhart,
Marder, & Carpenter, 2006). Thus, the American Psychiatric
Association's guide for clinical treatment has reported, “There are no
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treatments with proven efficacy for primary negative symptoms” (APA,
2004), pointing to an unmet therapeutic need and opening the door for
future intervention development.
3. The current review
Although there have been prior reviews focused on specific psycho-
social treatments in schizophrenia (e.g., Gould, Mueser, Bolton, Mays, &
Goff, 2001; Turkington, Dudley, Warman, & Beck, 2006), the current
review systematically and critically evaluates studies that have assessed
the impact of psychosocial interventions on negative symptoms.
Articles were identified via several databases (PubMed, PsycInfo,
and Google Scholar) using both broad (e.g. therapy [OR] psychosocial
[OR] treatment [AND] schizophrenia) and narrow (e.g. cognitive [OR]
behavioral [OR] psychoeducation [OR] social skills [AND] schizophrenia)
search terms (keywords and anywhere in the manuscript). Search
results were pared down to only include randomized control trials
and exclude medication efficacy studies, theoretical papers, case
studies, studies of high-risk populations, meta-analyses, and reviews.
Meta-analyses and reviews were, however, used in order to identify
additional studies that were not initially identified in the database
searches.
Of the studies identified, only a small number (n = 8) included
negative symptoms as a primary treatment outcome (Daniels, 1998;
Dobson, McDougall, Busheikin, & Aldous, 1995; Dyck et al., 2000;
Grant, Huh, Perivoliotis, Stolar, & Beck, 2012; Hayes, Halford, &
Varghese, 1995; Klingberg et al., 2009, 2011; Thorup et al., 2005;
Turkington, Dudley, et al., 2006; Turkington, Kingdon, et al., 2006),
and only one study (Klingberg et al., 2009, 2011) tested an intervention
explicitly designed to alleviate negative symptoms. Instead, the studies
reported here evaluated psychosocial interventions for schizophrenia
more broadly, and findings regarding negative symptoms were often
only briefly mentioned. In the current review, we opted to include psy-
chosocial interventionswith at least ten ormore randomized controlled
trials (RCT), reasoning that this would be a sufficient sample from
which to make comparisons across studies and conclusions regarding
the efficacy of a particular intervention for improving negative symp-
toms. Cognitive behavioral therapy (CBT), social skills training (SST),
and combined treatment interventions (i.e., more than one psychoso-
cial intervention delivered together) met this criterion of ten or more
RCTs that also reported on negative symptom outcomes. For each treat-
ment, we discuss the guiding theory aswell as the empirical support for
improving negative symptoms. Furthermore, we highlight strengths
and weaknesses of individual studies and of the larger body of findings
specific to each treatment approach and consider aspects of study
design. Tables 1–3 list information on all of the studies reviewed here,
including sample and size, nature of treatment and control interven-
tions, some study design details such as whether raters were blinded
to treatment condition, and effect sizes when they are reported. Finally,
in delineating future directions, we discuss recent innovations in the
treatment of negative symptoms and provide several important meth-
odological considerations that ought to be included in the next genera-
tion of efficacy and effectiveness studies.
4. Cognitive behavioral therapy
4.1. Guiding theory
Cognitive behavioral therapy (CBT) is a widely established and
effective transdiagnostic treatment (Beck, 2011). The cognitive model
suggests that the way in which we interpret events has consequences
for how we think, feel, and behave; these interpretations then act to
create and maintain unhelpful responses. The goals of CBT are di-
verse, ranging from specific symptom reduction, increased insight
and understanding of illness, distress reduction, and the develop-
ment of adaptive coping skills. CBT has more recently been applied
to the treatment of psychosis, and comprehensive manuals have been
developed (e.g., Hagen, Turkington, Berge, & Grawe, 2010; Kingdon &
Turkington, 2005). Indeed, CBT is the most widely studied intervention
of the three types we review here.
Cognitive models specific to schizophrenia symptoms have also
been developed (e.g., Beck & Rector, 2005; Garety, Kuipers, Fowler,
Freeman, & Bebbington, 2001; Morrison, 2001). Beck and Rector
(2005) advanced a cognitive conceptualization of negative symptoms,
arguing that negative beliefs about social abilities and performance,
as well as lower expectancies for pleasure and success, contribute to
the maintenance of negative symptomatology. For example, the belief
“I'm going to sound weird, stupid, or strange” may be related to symp-
toms of alogia or the thought “Why bother, I'm just going to fail” may
maintain symptoms of avolition. Kingdon and Turkington (2005) pro-
posed that negative symptoms result from reactions to high levels of
stress and a decreased ability to cope. Within this conceptualization,
affective flattening is believed to develop from demoralization, alogia
is a response to difficulty communicating in reaction to criticism,
avolition is driven by the perception of being under pressure and fail-
ing to meet expectations, anhedonia results from a sense of hopeless-
ness or numbness, and asociality is a maintaining factor that helps to
reduce stress by lowering overstimulation and stressful contexts.
Empirical studies have delineated associations between cognitive
distortions and the manifestation and maintenance of negative symp-
toms as well as functional impairment in schizophrenia. For example,
Grant and Beck (2009) found that defeatist beliefs about performance
abilities were associated with elevated negative symptoms and poorer
functioning. Thus, this cognitive distortionmay contribute to the avoid-
ance of meaningful goal related and pleasurable activities. In addition,
Grant and Beck (2010) found that asocial beliefs significantly predicted
interpersonal communication and prosocial behaviors one year later.
Horan et al. (2010) evaluated the relationship between dysfunctional
beliefs and negative symptoms, finding that people with higher defeat-
ist performance beliefs also experienced higher negative symptoms and
worse community functioning. Taken together, these studies point to an
important therapeutic target and suggest that interventions that reduce
cognitive distortions, in particular defeatist beliefs, may help to reduce
negative symptoms and improve functioning.
4.2. Empirical findings
Several reviews (Kern, Glynn, Horan, & Marder, 2009; Rector &
Beck, 2001; Tarrier & Wykes, 2004; Turkington, Dudley, et al., 2006;
Turkington, Kingdon, et al., 2006) and meta-analyses (Gould et al.,
2001; Pilling et al., 2002; Wykes et al., 2008; Zimmermann, Favrod,
Trieu, & Pomini, 2005) suggest that CBT is an effective adjunctive
treatment for persistent positive symptoms. However, the benefits
of CBT for negative symptoms are less clear. We identified 51 studies
that investigated the efficacy of CBT for treating schizophrenia. Of
these, 22 were RCTs that reported on negative symptom outcomes
(see Table 1). Sixteen of these evaluated individual CBT, four evaluated
group CBT, one evaluated a combination of individual and group CBT,
and one evaluated group CBT in comparison to social skills training
(SST; Lecomte et al., 2008; Lecomte, Leclerc, & Wykes, 2012), which
we discuss in the SST section.
4.2.1. CBT compared to non-active treatments
Eight studies compared CBT to a non-active treatment control
(e.g., treatment as usual, standard or routine care; wait-list); five pro-
vided individual CBT; and three provided group CBT. All of the indi-
vidual CBT studies found an improvement in negative symptoms
either at post treatment or follow-up; one of three group CBT studies
found improvement, but only for one of the two samples in the study.
Grant et al. (2012) randomly assigned people to individual cog-
nitive therapy (CT) or TAU. Those who received CT engaged in
18 months of weekly therapy sessions lasting 50 min. TAU varied
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Table 1
Cognitive behavioral therapy (CBT) and negative symptom outcomes.
Citation N/diagnosis Treatment/length of treatment Control Negative Sx
outcome
Raters
blind
Results Follow-up Effect size
Barrowclough
(2006)
113/SZ, SA Group CBT/6 months TAU PANSS Y No change in NSx No change 12 months 6/12 months
d = −1.45/−0.22
Bechdolf
(2004, 2005)
88/SZ, RD Group CBT/8 weeks Group PE 8 weeks PANSS Y ↓ NSx NS group diff Maintained at 6 months
Not maintained at 24 months
NR
NR
Borras (2009) 54/SZ, NP Group CBT — self-esteem/12
weeks (1st sample)
Waitlist 12 weeks then
treatment (2nd sample)
PANSS NR ↓ NSx CBT only
(1st sample only)
Maintained at 3 months
(1st sample only)
NR
Cather (2005) 30/SZ, SA Individual CBT/16 weeks Individual PE 16 weeks PANSS PSYRATS Y No change in NSx – CBT d = −0.10 PE
d = −0.14
Drury (1996) 62/ANP Group and individual CT/12 weeks Recreation and support group PAS Y ↓ NSx NS group diff Maintained at 9 months NR
Garety (2008) 301/NAP Individual CBT + TAU/individual
FI + TAU
TAU PANSS Y No Change in NSx at
12 months
No change in NSx at 24 months 12/24 months
d = −0.87/−1.32
Grant (2012) 60/SZ, SA Individual CT/18 months TAU SANS Y ↓ Avolition-apathy
subscale CBT only
– d = −2.16
Gumley (2003) 144/SZ, RD Individual CBT/range (2–16 sessions) TAU PANSS N ↓ NSx CBT only – NR
Hall (2003) 25/PD Individual CBT — self-esteem/7 weeks TAU PANSS Y ↓ NSx CBT only Maintained at 3 months NR
Jackson (2008) 62/FEP Individual ACE/14 weeks Befriending SANS Y No change in NSx No change at 12 months d = −0.40
Klingberg
(2009, 2011)
198/SZ Individual CBT/9 months CR PANSS Y ↓ NSx NS group diff – d = −0.47
Leclerc (2000) 99/SZ, SA, PP Group CBT — coping skills/12 weeks TAU PANSS Y No change in NSx No change at 6 months NR
Lincoln (2012) 80/SZ, SA, DD, BPD Individual CBT/4 months Waitlist PANSS N No change in Nsx No change at 12 months Post/12 months
d = 0.14/0.28
Rector (2003) 42/SZ, SA Individual CBT/6 months TAU PANSS Y ↓ NSx NS group diff Maintained at 6 months CBT only Post/6 months
d = 0.45/0.85
Sensky (2000),
Turkington
(2008)
90/SZ Individual CBT/9 months Befriending SANS Y ↓ NSx NS group diff Maintained at 6 months BT
only maintained at 60 months
CBT only
NR
NR
Startup (2004) 90/SZ, SP, SA Individual CBT/Mean = 12.9 sessions TAU SANS N No change in Nsx ↓ NSx at 12 months CBT only Post/12 months
d = 0.33/0.66
Tarrier (1993) 27/SZ Individual CSE/PS/10 sessions Waitlist PAS N No change in NSx No change at 6 months NR
Tarrier (2001) 72/SZ, SA, DD Individual CBT/20 sessions SC, TAU SANS Y ↓ NSx – NR
Tarrier (2004),
Lewis (2002)
316/SZ, SA SP, DD, Pnos Individual CBT/15–20 sessions within
5 weeks
SC, TAU PANSS Y NR ↓ NSx CBT and SC at 18 months d = −1.51
Turkington
(2002, 2006)
336/SZ Individual CBT/6 sessions within
2–3 months
TAU NSRS Y NR ↓ NSx CBT only at 12 months NR
Valmaggia
(2005)
62/SZ Individual CBT/22 weeks Supportive counseling PANSS Y No change in NSx No change at 6 months Post/6 months
d = 0.37/0.01
Note. Studies in this table are identified by first author surname and year rather than a full citation, as in the references and throughout the text. Raters blind = were the raters blind to subject status; ACE = Active Cognitive Therapy for
Early Psychosis; ANP = Acute nonspecific psychosis (schizophrenia, schizoaffective disorder, delusional disorder); BPD = brief psychotic disorder; CR = Cognitive Remediation; CT = Cognitive Therapy; CSE = Coping Strategy
Enhancement; DD = Delusional disorder; diff = difference; FEP = First Episode Psychosis; FI = family intervention; NAP = non-affective psychosis; N = no; NP = non-specific psychosis; NR = not reported; NS = non-significant;
NSRS = Negative Symptom Rating Scale; NSx = negative symptoms; PANSS = Positive and Negative Syndrome Scale; PAS = Psychiatric Assessment Scale; PD = psychotic disorder; PE = Psychoeducation; Pnos = psychosis not
otherwise specified; PS = problem solving; PSYRATS = Psychotic Rating Scales; RD = Related disorders; SA = schizoaffective disorder; SANS = Scale for Assessment of Negative Symptoms; SP = schizophreniform; SZ =
schizophrenia; TAU = treatment as usual; Y = yes; ↓ = significant decrease in scores.
917
O
.Elis
et
al./ClinicalPsychology
Review
33
(2013)
914
–928
by person, but at a minimum included medications and often com-
posed of common community resources (e.g., case management,
day treatment, vocational rehabilitation, etc.). Upon completion of
the treatment, those who received CT showed greater improvement
on the avolition-apathy subscale of the Scale for the Assessment of
Negative Symptoms (SANS; Andreasen, 1982) compared to those who
received TAU. Another RCT of CBT (ranging from two to 16 individual
sessions) and TAU (access to community mental health, ongoing medi-
cation, and routine psychiatric review and follow-up) reported that
people who received CBT showed significantly greater improvement
on the negative symptom scale of the Positive and Negative Syndrome
Scale (PANSS; Kay, Fiszbein, & Opler, 1987) compared to those who re-
ceived TAU (Gumley et al., 2003).
Tarrier et al. (2001) compared people randomly assigned to ten
weeks of individual CBT, supportive counseling (emotional support
and unconditional regard), or TAU (medication management and
monitoring through outpatient follow-up and case management).
All groups showed an improvement in total SANS scores. However,
people who received CBT evidenced a trend for greater improvement
compared to TAU (p = .07). Furthermore, people who received CBT
showed a trend for greater improvement on the alogia subscale
(p = .06), but not the other subscales, compared to people in sup-
portive counseling group. Hall and Tarrier (2003) compared individ-
ual CBT focused on self-esteem with TAU in a small RCT of people
recently admitted to an acute psychiatric unit. While hospitalized,
TAU consisted of medication, clinical assessment, and routine therapy
sessions (e.g., anger management, craft and exercise groups). Upon
discharge, TAU included visits from community workers and three
monthly outpatient appointments with a psychiatrist. In addition to
the TAU services provided to all people, CBT consisted of seven weekly
individual sessions where sessions focused on identifying positive
qualities and using past and current experiences to increase the belief
of these traits. People assigned to receive CBT-self-esteem showed
a greater improvement in PANSS negative symptom scores post-
intervention and at 3-month follow-up than people assigned to TAU.
In an effectiveness study of individual CBT for psychosis (CBTp)
in a routine clinical practice setting, Lincoln et al. (2012) found no
difference in the post-treatment PANSS negative symptom scores
between people who were randomly assigned to four months of CBTp
compared to a wait-list control. However, at the one year follow-up,
35% of the people who completed CBTp evidenced a clinically signif-
icant change in negative symptoms (i.e., a reliable improvement)
and just over half (55%) were considered part of the healthy popula-
tion suggesting a modest effect.
Barrowclough et al. (2006) reported no improvement in the PANSS
negative symptom scores of people who were randomly assigned to
participate in a six-month group CBT intervention or people who re-
ceived TAU (medication management, outpatient and community
follow-up, and access to community-based rehabilitation programs)
at post-treatment or at the 12-month follow-up. An RCT of a 24-session
coping skills CBT group compared to TAU (defined as “regular rehabili-
tation treatment”) reported no improvement in PANSS negative symp-
toms at post-treatment or at six-month follow-up (Leclerc, Lesage,
Ricard, Lecomte, & Cyr, 2000).
In a randomized crossover trial of a 12-week (24 session) group
CBT self-esteem intervention, Borras et al. (2009) reported mixed re-
sults with only one of the two study samples demonstrating an im-
provement in PANSS negative symptoms at post-treatment and
three months later. Although there was no difference in baseline
negative symptom scores between people in the two samples, they
received different types of adjunctive care (i.e., some received case
management as well, others did not).
4.2.2. CBT compared to active treatment
Eight studies compared CBT to an active control treatment; seven
provided individual CBT, and one provided a combination of individ-
ual and group CBT. Three studies found comparable improvement in
negative symptoms in both CBT and the active control, findings that
are consistent with a recent meta-analysis of CBT compared to other
psychosocial treatments (Jones, Hacker, Corman, Meaden, & Irving,
2012). However, five other studies found no improvement in either
treatment condition.
In amultisite RCT, Klingberg et al. (2009, 2011) compared individual
CBT to Cognitive Remediation (CR). CR focused on training attention,
memory, and executive functioning using a series of highly structured
computer programs. They found a significant improvement on the
PANSS negative symptom scale for both CBT and CR treatments, with
no between-group differences, suggesting that both interventions
were effective. Drury, Birchwood, Cochrane, and Macmillan (1996)
found that people randomly assigned to either group and individual
cognitive therapy, or recreation and support therapy (an active control
designed tomatch therapist hours and provide structured activities and
informal support) showed comparable improvement in negative symp-
toms asmeasured by the Psychiatric Assessment Scale (PAS; Krawiecka,
Goldberg, & Vaughan, 1977) after treatment and at the nine month
follow-up. Finally, Lewis et al. (2002) randomly assigned people in
their first or second acute hospital admission for psychosis to five
weeks of individual CBT or supportive counseling (amanualized control
Table 2
Social skills training (SST) and negative symptom outcomes.
Citation N/diagnosis Treatment/length
of treatment
Control Negative Sx
outcome
Raters
blind
Results Follow-up Effect size
Dobson
(1995)
28/SZ Group SST/9 weeks Group Milieu
9 weeks
PANSS NR ↓ NSx SST only Maintained at 3 months
both groups; Not
maintained at 6 months
(data for SST only)
NR
Hayes (1995) 63/SZ Group SST/18 weeks Discussion group
18 weeks
SANS NR No change in NSx No change at 6 months NR
Horan (2009) 31/SZ, SA Group SCST/6 weeks Relapse prevention
group 6 weeks
BPRS: anergia N ↓ NSx SCST only – η2 = −0.18
Lecomte
(2008, 2012)
129/SZspec,
MDP, Pnos
Group SST/group
CBT/3 months
Waitlist BPRS: negative Y ↓ NSx CBT and SST Not maintained at 6 months
or at 12 months
η2 = 0.25–0.54
follow-up: NR
Rus-Calafell
(2013)
31/SZ, SA Group SST/16 sessions TAU PANSS N ↓NSx SST only Maintained at 6 months Follow-up: d = 0.39
Sanz (2009) 14/SZ Group SCST/10 weeks TAU PANSS NR No change in NSx – NR
Xiang (2006) 96/SZ Group CRM/8 weeks Group SC PANSS Y ↓NSx CRM only Maintained at 6 months NR
Note. Studies in this table are identified by first author surname and year rather than a full citation, as in the references and throughout the text. Raters blind = were the raters
blind to subject status; BPRS = Brief Psychiatric Rating Scale; CBT = cognitive behavioral therapy; CRM = Cognitive Remediation; MDP: mood disorder with psychotic
features; N = no; NR = not reported; NS = non-significant; NSx = negative symptoms; PANSS = Positive and Negative Syndrome Scale; Pnos = psychosis not otherwise
specified; SA = schizoaffective disorder; SANS = Scale for Assessment of Negative Symptoms; SC = supportive counseling; SCST = Social Cognitive Skills Training; SZ =
schizophrenia; SZspec = schizophrenia spectrum; TAU = treatment as usual; Y = yes; ↓ = significant decrease in scores.
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Table 3
Combined treatments and negative symptom outcomes.
Citation N/Diagnosis Treatment/length
of treatment
Control Negative Sx
outcome
Raters
blind
Results Follow-up Effect size
Barrowclough (2001) 30/SZ + SUD,
SA + SUD
IIP/9 months TAU PANSS Y ↓ NSx IIP only Not maintained
at 3 months
NR
Bradley (2006) 59/SZ, SA, SP MFG + PE/12 months TAU SANS Y No change in NSx – NR
Buchkremer (1997) 132/SZ PE + leisure/PE + leisure + family
PE/PE + CT/PE +
CT + family PE 8 months
10–20 sessions
Leisure group SANS N No change in NSx No change at 12
or 24 months
NR
Daniels (1998) 40/SZ, SA Group IBT/8 weeks Waitlist SANS Y No change in NSx – NR
Dyck (2000) 63/PD MFG/12 months TAU SANS Y ↓ NSx MFG only – NR
Girón (2010) 50/SZ, SP Individual FT + individual
counseling + TAU 2 years
Individual
counseling + TAU
WHO-DAS Y ↓ NSx FT group only – NR
Granholm (2005) 76/SZ, SA Group SST + CBT/24 sessions TAU PANSS Y No change in NSx – η2 = 0.01
Hansen (2012) 62/SZspec CAT + ACT/6 months ACT PANSS Y No change in NSx No change at
3 months
NR
Hogarty (1991) 103/SZ, SA Family PE/SST/SST + family
PE/24 months
TAU Wing: social withdrawal Y ↓ NSx family PE and family
PE + SST only
– NR
Hogarty (1997) 151/SZ, SA PT + FT + PE/ PT 36 months Wing N ↓ NSx PT + FT + PE only
at 18 and 24 months
– 18/24 months
d = 0.35/0.39
Magliano (2006) 71/SZ FT + PE/6 months Waitlist BPRS: negative NR No change in NSx – NR
McFarlane (1996) 68/SZ, SA, SP MFG + PE + ACT/24 months Crisis family intervention
+ ACT
PANSS Y ↓ NSx NS group diff; – NR
Palma-Sevillano (2011) 34/SZ CMT/12 months TAU PANSS Y ↓NSx CMT only – η2 = 0.53
Petersen (2005),
Thorup (2005)
547/SZspec IT/24 months TAU SANS N ↓NSx IT only at 12 and
24 months
– 12/24 months
d = 0.31/0.34
Pinto (1999) 41/SZ CBT + SST/6 months SC SANS NR ↓ NSx NS group diff – NR
Rosenbaum (2005, 2006) 562/SZspec Supportive/MFG + ACT +
SST/12–36 months
TAU PANSS NR ↓ NSx NS group diff ↓ NSx both
groups at 12 and
24 months
NR
NR
Valencia (2007) 82/SZ FT + SST/12 months TAU PANSS Y ↓ NSx FT + STT only – d = 2.0
Yildiz (2004) 30/SZ SST + Family PE/8 months TAU PANSS Y ↓ NSx SST + Family PE only – NR
Note. Studies in this table are identified by first author surname and year rather than a full citation, as in the references and throughout the text. Raters blind = were the raters blind to subject status; ACT = assertive community treatment;
BPRS = Brief Psychiatric Rating Scale; CAT = cognitive adaptation training; CBT = cognitive behavioral therapy; CMT = cognitive motivational therapy; CT = cognitive therapy; diff = difference; FT = family therapy; IBT =
Interactive-Behavioral Training; IIP = Integrated Intervention Program; IT = integrated treatment; MFG = multi-family group therapy; N = No; NR = not reported; NS = non-significant; NSx = negative symptoms; PANSS =
Positive and Negative Syndrome Scale; PD = psychotic disorder; PE = psychoeducation; PT = personal therapy; SA = schizoaffective disorder; SANS = Scale for Assessment of Negative Symptoms; SC = supportive counseling;
SUD = substance use disorder; SP = schizophreniform; SST = social skills training; SZ = schizophrenia; SZspec = schizophrenia spectrum; TAU = treatment as usual; Wing = Wing Negative Symptom Scale; WHO-DAS = World
Health Organization Psychiatric Disability Assessment Schedule; Y = yes; ↓ = significant decrease in scores.
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therapy matched for therapist exposure) and found that those who re-
ceived CBT had a significant improvement in overall symptoms at post-
intervention (negative symptoms results were not reported) compared
to those who received TAU (unspecified across participants with the
exception that it always includedmedication and day or inpatient treat-
ment. However, both groups showed similar improvement in PANSS
negative subscale scores 18 months following treatment compared to
TAU (Tarrier et al., 2004).
Five other studies comparing CBT to and active control treatment
found no improvement in negative symptoms. Valmaggia, van der
Gaag, Tarrier, Pijnenborg, and Slooff (2005) compared 16 hours of in-
dividual CBT to 16 hours of supportive counseling (emotional support
and unconditional regard) and reported no significant improvement
on the PANSS in either treatment condition. Results from a small
RCT of individual functional CBT, a treatment focused on decreasing
psychiatric symptoms and improving social functioning, found no
improvement in negative symptoms at pre- and post-intervention
in either the 16 session treatment condition or the 16 session
psychoeducation control group (Cather et al., 2005). The remaining
two studies included treatments that diverged slightly from more
traditional CBT approaches. Tarrier et al. (1993) randomly assigned
people to an individual coping strategy enhancement therapy (CSE;
focused on learning skills to monitor symptoms, identify maintaining
factors, and develop coping skills to decrease distress), individual prob-
lem solving therapy (PS; focused on learning skills to improve cogni-
tive flexibility in an effort to increase problem solving abilities), or a
waitlist control. They found no significant improvement on the nega-
tive symptom composite score of the PAS and no clinically significant
change, as defined by a 50% or more reduction in an individual's
total symptom severity score and an increase in social functioning of
at least one standard deviation, in any of the three groups at
post-treatment or at the six-month follow-up. Jackson et al. (2008)
found no improvement (post-treatment and at one year follow-up)
in SANS negative symptom scores for people receiving either individual
cognitive therapy or a befriending control condition (Jackson et al.,
2008). Garety et al. (2008) found no improvement on the PANSS nega-
tive scale at post-treatment or at 24-month follow-up for people receiv-
ing either individual CBT or an individual family intervention compared
to TAU. However, in a follow-up exploratory analysis, they found that
people with caregivers showed improved scores on the PANSS negative
scale at 12-months irrespective ofwhether they received CBT or the fam-
ily intervention; this was not maintained at 24-months (Garety et al.,
2008).
4.2.3. Do the effects of CBT persist?
In addition to the five studies reported earlier that suggest mainte-
nance or emergence of negative symptom improvement at follow-up
(i.e., Borras et al., 2009; Drury et al., 1996; Hall & Tarrier, 2003;
Lincoln et al., 2012; Tarrier et al., 2004), five additional treatment trials
suggest that the effects of CBT persist or emerge beyond the post-
treatment assessment. Four trials (Bechdolf et al., 2004; Rector,
Seeman, & Segal, 2002; Startup, Jackson, & Bendix, 2004; Turkington,
Kingdon, & Turner, 2002; Turkington,Kingdon, et al., 2006) found that
CBT was more effective than TAU three to 12 months after treatment,
and one trial (Sensky et al., 2000; Turkington et al., 2008) found that
CBT was more effective than an active treatment control five years
after treatment.
Startup et al. (2004) found no difference in negative symptoms in
those randomly assigned to participate in 12–15 90-min. individual CBT
sessions or TAU (medication and nursing care during hospitalization
and community care after discharge) at post-treatment, but significant
improvement in negative symptoms at the 12 month follow-up in
those who received CBT. Further, 60% of the people in the CBT group
showed clinically significant change, as measured by a change in an
individual's Global Functioning Scale score within two standard de-
viations of the normative mean, compared to 40% in the TAU group.
Rector et al. (2002) reported significant improvement on the PANSS
negative subscales at post-intervention for people who received
20-session individual CBT as well as for people who received TAU
(comprehensive psychiatric management with medication optimiza-
tion, clinical case management, and specialized schizophrenia treat-
ment services). However, at the six-month follow-up only those who
received CBT maintained continued improvement in PANSS negative
symptom scores. Turkington et al. (2002) randomly assigned people
to six individual sessions of CBT or TAU (freely determined by their
community mental health team) and found that those who received
CBT had a significant improvement in overall symptoms at post-
intervention compared to thosewho received TAU (negative symptoms
results were not reported at post-treatment). However, at one year
post-treatment, only people who received CBT showed a significant
improvement on the Negative Symptom Rating Scale (NSRS; Hansen,
Turkington, Kingdon, & Smith, 2003) and a clinically significant change
of 25% ormore in insight and negative symptoms (Turkington, Kingdon,
et al., 2006).
When comparing CBTwith active treatment controls, anRCT found a
significant improvement in PANSS negative symptom scores in both
group CBT (16 sessions) and group psychoeducation (8 sessions) at
post-treatment and at a six-month follow-up, with no significant
differences between treatment conditions or clinically significant
change in individual symptom improvement (Bechdolf et al., 2004). At
24-month follow-up (Bechdolf, Kohn, Knost, Pukrop, & Klosterkotter,
2005), however, negative symptom scores were no longer significantly
different from pre-treatment scores for either group, likely due to the
much smaller numbers of people included in this follow-up (i.e., 60%
in CBT and 42% in psychoeducation lost at 24-month follow-up). An
RCT by Sensky et al. (2000) compared 18 individual CBT sessions to a
befriending intervention, a control condition designed to match thera-
pist contact time and involved a nondirective and empathetic discussion
of neutral topics, and found that both treatmentswere associatedwith a
significant improvement in the SANS at post-treatment. However, only
people who received CBTmaintained those improvements and showed
clinically significant change, as defined by a 50% ormore reduction in an
individual's negative symptom baseline scores at five-year follow-up
(Turkington et al., 2008). These studies suggest that while CBT may be
as effective as other psychosocial treatments in improving negative
symptoms upon treatment completion, people who receive CBT may
be more likely to maintain these benefits over time.
4.3. Summary
We reviewed 21 CBT studies (one additional study of CBT compared
to SST is discussed in the SST section; Lecomte et al., 2008, 2012) that in-
cluded negative symptoms as a treatment outcome. Over half (n = 12)
of the studies compared CBT to an inactive control (TAUorwaitlist), and
the others (n = 9) compared CBT to another active treatment. Overall,
13 of the 21 studies found that CBT was associated with an improve-
ment in negative symptoms, either at post-treatment or follow-up.
Five of the eight studies that did not report improvements in nega-
tive symptoms included an active control group (befriending thera-
py, supportive therapy, psychoeducation, family therapy). Taken
together, these studies suggest that individual CBT can be effective for
improving negative symptoms. However, the efficacy of group CBT is
less clear, in part due to the smaller number of studies that have been
conducted. Of the five studies that investigated group CBT, three studies
showed evidence of improvement (Bechdolf et al., 2004; Borras et al.,
2009; Drury et al., 1996). However, group CBT in two of these studies
did not demonstrate benefits above that of other active control treat-
ments. Thus, additional research is needed to confirm its efficacy. This
is particularly important because group interventions are often more
commonly used in community mental health settings, where most
people with schizophrenia receive treatment services.
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Although continued investigation of CBT interventions for negative
symptoms is necessary to determine effectiveness, there is room for
optimism. CBT is guided by cognitive theory,which has strong empirical
support, the results of RCTs for CBT have shown mostly positive short-
term and long-term outcomes and CBT is the only psychosocial inter-
vention reported by PORT treatment recommendations for schizophre-
nia with some evidence for improving negative symptoms (Dixon et al.,
2010). Given the preliminary evidence suggesting that the benefits
of CBT persist over time, it is essential that future studies include
follow-up assessments in order to fully evaluate the clinical benefits
of this treatment approach.
5. Social skills training
5.1. Guiding theory
Social skills training (SST) for schizophrenia was developed to
help people with schizophrenia with difficulties in interpersonal
situations and relationships. SST comes from a behavioral model
that targets improving a person's ability to function appropriately
and skillfully within social interactions, particularly in light of factors
thatmay otherwisemake social interactions challenging (e.g., psychotic
symptoms, motivational factors, affective states, environmental factors,
and neurobiological factors) (Bellack, Muesser, Gingerich, & Agresta,
2004).
The goal of SST is to help a person gain skills to achieve social com-
petence, which is typically defined by a distinct set of components,
including expressive, receptive, and conversation skills, and any other
factors that may impact a person's ability to engage in social interac-
tions (e.g., assertiveness skills, situational factors, independent living
skills, and medication management; Bellack et al., 2004). Expressive
skills include verbal behaviors (including verbal content, form, struc-
ture, appropriate vocabulary and amount of speech), paralinguistic be-
haviors (including the volume, pace, intonation and pitch of speech),
and nonverbal behaviors (including appropriate facial expression, eye
contact, body language, and proxemics). Receptive skills include the
ability to attend to the person with whom you are engaging (including
listening, getting clarification, relevance, timing), as well as emotion
perception skills (i.e., the ability to accurately perceive the emotions
of the person to whom you are attending). Conversational skills include
the ability to initiate, maintain, and appropriately end a conversation, as
well as building upon receptive skills.
5.2. Empirical findings
We identified 21 published articles that investigated the efficacy
of SST for treating schizophrenia. Eleven of these were RCTs that re-
ported on negative symptom outcomes (see Table 2). Four studies
incorporated SST with at least one other treatment modality (Granholm
et al., 2005; Hogarty et al., 1991; Pinto, La Pia, Mennella, Giorgio, &
DeSimone, 1999; Yildiz, Veznedaroglu, Eryavuz, & Kayahan, 2004), and
we thus review these in the next section on Combined treatments.
Of the remaining seven studies, five found significant improvement in
negative symptoms.
5.2.1. SST compared to TAU
One RCT compared group SST, which included modules presented
over sixteen sessions that focused on social perception, social informa-
tion processing, responding and sending skills, affiliative skills, instru-
mental role skills, interactional skills, and behavior governed by social
norms to TAU (Rus-Calafell, Gutierrez-Maldonado, Ortega-Bravo, Ribas-
Sabate, & Caqueo-Urizar, 2013). TAU consisted of individual sessions
with a psychiatrist, psychologist, and social worker and provided in-
dividual psychotherapy (including CBT), medication management,
and family support. Compared to TAU, people in the SST groups
showed an improvement in negative symptoms as measured by
the PANSS, and this improvement was maintained at six months
(Rus-Calafell et al., 2013).
A second, small RCT compared social perception training (learning
about emotions, identifying complex social situations) to TAU and
found no significant improvement on the PANSS negative symptom
subscale for either treatment from pre- to post-treatment, perhaps a
reflection of the very small sample size (Sanz et al., 2009).
5.2.2. SST compared to an active control treatment
One RCT compared group social cognition skills training (SCST) to
a modified version of the UCLA social and independent living skills
program, including illness management and relapse prevention; Horan
et al., 2009). SCST was developed to improve four domains related to
social cognition (facial affect perception, social perception, attributional
style, and theory of mind) by the use of instructional videotapes and
PowerPoint presentations, didactic learning, as well as modeling and
social reinforcement. Over sixweeks, people in the SCST group attended
one-hour sessions twice a week. Compared to the active control, those
who received SCST exhibited an improvement on the Brief Psychiatric
Rating Scale (BPRS; Overall & Gorham, 1962) anergia scale.
Another RCT also compared sixteen sessions of a group community
rehabilitation module (CRM) of the UCLA social and independent
living skills program with supportive group counseling. Both treat-
ments consisted of groups of six to eight people who met biweekly.
Following treatment, people in the CRM group showed a significant
improvement in negative symptoms as assessed by the PANSS than
those in supportive counseling; this effect persisted at the six-month
follow-up (Xiang et al., 2006).
Lecomte et al. (2008) randomly assigned people to group CBTp,
SST, or a wait-list control. The CBTp and SST groups met twice a week
for 24 weeks over the course of eight months. They found that people
in both active treatment groups (CBTp and SST) had significantly im-
proved scores on the BPRS negative symptom scale at post-treatment,
but not at the six-month follow-up. At the one-year follow-up, people
who received CBTp tended (p = 0.06) to maintain the improvements
in negative symptoms (Lecomte et al., 2012).
An RCT by Dobson et al. (1995) compared group SST with Milieu
therapy (i.e. choice of structured activities, including discussion groups).
Over the course of nine weeks, the SST group met weekly for four
one-hour sessions; the Milieu therapy group was more flexible, but ac-
tivities were available for the same length of time as the SST condition.
Symptoms were assessed via the PANSS pre-treatment, at three-week
intervals throughout nine weeks of treatment, and at three- and six-
month follow-ups; six-month follow-up datawas only available for par-
ticipants in the SST group. At post-treatment, people who received SST
had a greater improvement in negative symptoms than those receiving
Milieu therapy. However, this group difference did not persist at the
three-month follow-up and neither group showed an improvement
from pre-treatment at the six-month follow-up.
Finally, one RCT comparing SST to an active control treatment did
not find a significant improvement in negative symptoms. This RCT
compared eighteen weeks of SST to a discussion group. The discussion
group focused on interpersonal relationships and purposeful use of
time, but did not explicitly teach or demonstrate social skills. Neither
group evidenced an improvement in negative symptoms on the
SANS immediately post-group and at six-month follow-up (Hayes
et al., 1995).
5.3. Summary
We reviewed seven RCTs of SST that reported negative symptom
outcomes. Two studies compared SST to TAU and the remaining stud-
ies compared SST to an active control. Overall, five of these studies
found that SST was associated with an improvement in negative
symptoms post-treatment. Four of these studies also assessed negative
symptoms at follow-up; two studies reported that these gains were
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maintained at six-month follow-up (Rus-Calafell et al., 2013; Xiang et
al., 2006), one study reported that gains were maintained at the
three-month follow-up, but not at six-months (Dobson et al., 1995),
and one reported that gains were not maintained at six-month
follow-up (Lecomte et al., 2008). Although SST was not initially con-
ceptualized as a treatment for negative symptoms, taken together,
these studies suggest that SST can be effective for improving nega-
tive symptoms in the short-term.
6. Combined treatments
This section includes studies of combined treatment packages in
which two or more interventions are provided together and not tested
separately so there is noway to tell if either onewasmore effective than
the other. Many of these studies include family therapy and/or psycho-
education as components of the treatment package, and so some back-
ground on these two approaches will be provided. We also found addi-
tional CBT and SST studies thatwere combinedwith another treatment,
and include them in this discussion as well.
6.1. Guiding theory: family therapy
Family therapy focuses on examining and changing existing
patterns and dynamics between members of a family, which can
be defined as a couple, nuclear family, extended family, or the relation-
ship between a family and other interpersonal systems (Wynne, 1988).
These patterns are believed to play a role in the creation and mainte-
nance of problematic behaviors, including those that affect interper-
sonal relationships as well as the various symptoms associated with
psychological disorders. Many types of family therapy are based in
systems theory, which postulates that it is impossible to understand
the individual without understanding the dynamics and relationships
in their interpersonal environment (Doherty & McDaniel, 2010).
The primary goal of family therapy in schizophrenia is to focus on
changing family relationships and interpersonal interactions as a way
to facilitate symptom alleviation and recovery (Doherty & McDaniel,
2010) This typically involves engaging the family in treatment as
early as possible, education regarding the disorder, recommendations
for coping, communication training, problem-solving training, and
crisis intervention; it may or may not include the addition of a specific
psychoeducational family program (Goldstein & Miklowitz, 1995).
Communication deviance, or the extent to which a person is unable
to establish and maintain a shared focus of attention with a listener, is
often a key outcome in family therapy studies in schizophrenia. Studies
have indicated that the parents of young adults with schizophrenia have
higher levels of communication deviance than do parents of young
adults with other disorders (Miklowitz et al., 1986). Because family
therapy in schizophrenia often includes psychoeducation, distinguishing
the two approaches is often not possible.
6.2. Guiding theory: psychoeducation
Psychoeducation is derived from the diathesis–stress model (Zubin
& Spring, 1977), a model that focuses on the interaction between a pre-
disposition toward disease— the diathesis— and environmental, or life,
disturbances— the stress. Education and information about potentially
stressful or triggering behaviors, attitudes or responses can help people
avoid creating the types of situations that would exacerbate the likeli-
hood of relapse symptom exacerbation (Lefley, 2009). Psychoeducation
for schizophrenia includes sessions— usually in groups— duringwhich
people are given pertinent information about the disorder, including in-
formation about symptoms, how to distinguish symptoms fromperson-
ality, the importance of medication, accepting a vulnerability to future
episodes, the role of stressful life events in triggering symptoms and ep-
isodes, as well as how to recognize triggering behaviors, attitudes, and
responses (Goldstein & Miklowitz, 1995).
6.3. Empirical findings
We identified 58 combined treatment studies that included some
combination of family therapy, psychoeducation, CBT, or SST. Eighteen
of these were RCTs that reported on negative symptom outcomes
(see Table 3). Of these, 12 reported improvements in negative symptoms.
6.3.1. Combined treatments with family therapy
We identified three studies of either individual or multi-family
group therapy in combination with another treatment modality that
was compared to TAU alone (Bradley et al., 2006; Petersen et al.,
2005; Valencia, Rascon, Juarez, & Murow, 2007), and three others that
compared family therapy in combination with another treatment to
an active treatment control group (Hansen, Østergaard, Nordentoft, &
Hounsgaard, 2012; Hogarty et al., 1997; McFarlane, Dushay, Stastny,
Deakins, & Link, 1996). We also identified two studies that compared
individual (Girón et al., 2010) or multi-group family therapy (Dyck
et al., 2000) to TAU. Despite the fact that these studies were not com-
bined treatments per se, we include them here because they are the
only two from which the effects of family therapy can be disentangled
from the effects of other treatments; both suggest that multi-group fam-
ily therapy can be beneficial for negative symptoms. Two other studies
incorporated a family therapy component with CBT or psychoeducation
(Barrowclough et al., 2001; Magliano et al., 2006) and will be discussed
in the Combined treatments with psychoeducation and Combined
treatments with SST or CBT sections, respectively.
An RCT by Valencia et al. (2007) compared 48 weekly sessions of
social skills trainingplus family therapy to TAU,which includedmedica-
tion management and 20-min. monthly appointments. People who re-
ceived the combined social skills and family therapy had significant
negative symptom improvement as assessed by the PANSS compared
to people who received TAU. In contrast, Bradley et al. (2006) did
not find significant improvement in negative symptoms on the SANS
between a multiple-family-group combined with psychoeducation to
TAU over the course of 12 months.
A 2005 RCT compared two years of an integrated therapy (IT) with
TAU in participants with a first episode of psychosis (Petersen et al.,
2005; Thorup et al., 2005). IT consisted of assertive community treat-
ment (ACT), social skill training, and multifamily groups, whereas TAU
involved “typical treatment” in community health centers. At the one-
and two-year assessments, people who received IT had significantly
greater improvement on the SANS compared to people who received
TAU (Petersen et al., 2005); at the two-year assessment people re-
ceiving the combined treatment also had significantly greater im-
provement on the affective flattening, alogia, avolition/apathy, and
anhedonia/asociality subscales of the SANS (Thorup et al., 2005).
Hansen et al. (2012) compared IT (Petersen et al., 2005; Thorup
et al., 2005) plus cognitive adaptation training and assertive commu-
nication treatment (ACT) to IT plus ACT. Cognitive adaption training
involves providing supports (e.g., signs, checklists, alarms) to deal
with cognitive problems (e.g. forgetting). Assertive community train-
ing is an intensive, integrative approach that provides most psychiat-
ric services in people's living environments rather than in an office or
clinic (Mueser, Bond, Drake, & Resnick, 1998). Neither group showed
an improvement in negative symptoms on the PANSS post-treatment
or at the three-month follow-up.
Another RCT compared the efficacy of MFG plus ACT to ACT + a
crisis family intervention over the course of two years (McFarlane
et al., 1996). Crisis family intervention involved interactions with
treatment providers only when a family crisis arose. Both groups
exhibited significant improvements in negative symptoms as assessed
by the PANSS, with no significant differences between groups.
Hogarty et al. (1997) randomly assigned people to either personal
therapy (PT), which focused on affective regulation and personal/social
adjustment, or PT plus family therapy over the course of three years.
Participants who lived with a family member were assigned to receive
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PT plus family therapy, which also included family psychoeducation.
Compared to people who received PT alone, people who received PT
plus family therapy showed significant improvements in negative
symptoms on the Wing Negative Symptom Scale (Wing, 1961). Most
of the treatment effects occurred in the second and third years of ther-
apy, suggesting that longer interventions may be needed.
The two studies comparing multifamily group therapy (MFG) to
TAU found that MFG was superior. Girón et al., 2010 compared
24 months of MFG to TAU. The family intervention was integrated
with a six-session module to teach empathy. For the first nine months
the group met every other week. After nine months, the group met
monthly for the next fifteen months. TAU consisted of support, home
visits, social work, medication, and individual therapy that included
psychological support and problem-solving. People who received MFG
had a significant improvement in negative symptom as assessed with
the Spanish version of the World Health Organization Psychiatric Dis-
ability Assessment Schedule (WHO-DAS; WHO, 1988) compared to
people receiving TAU.
Dyck et al. (2000) randomly assigned people to MFG or TAU. MFG
consisted of weekly sessions that included both people with schizo-
phrenia and their families, biweekly sessions that only included the
family as well as TAU. TAU involved meetings with a case manager,
nurse, psychiatrist, and social worker for medication and case man-
agement, along with unspecified “therapeutic and rehabilitative”
services. Post-treatment, people who received MFG had significantly
improved scores on the SANS global score, compared to people who
received TAU alone.
6.3.2. Combined treatments with psychoeducation
We identified three studies that combined psychoeducation with
least one other treatment modality (Buchkremer, Klingberg, Holle,
Schulze Mönking, & Hornung, 1997; Magliano et al., 2006; Rosenbaum
et al., 2005, 2006). One of these studies found a significant improve-
ment in negative symptoms for a combined treatment involving
psychoeducation.
A multi-site, partial RCT (random assignment to groups for two-
thirds of the study sample) compared the effects of two active treat-
ment conditions to TAU, in people with a first episode of psychosis
(Rosenbaum et al., 2005, 2006). The first active treatment condition
was individual or group supportive therapy; the second was assertive
community training (ACT) plus multi-family psychoeducational group
therapy. TAU was not standardized across participants, but consisted
of psychological interventions,medication, and treatment administered
according to individual needs and available resources. Compared to
people who received TAU, people who received either active treatment
exhibited an improvement on the PANSS negative symptom scale after
one year (Rosenbaum et al., 2005). Furthermore, at the two-year
follow-up that included 80% of the original participants, negative symp-
toms continued to improve on the PANSS negative symptoms scale in
both active treatment groups (Rosenbaum et al., 2006).
An RCT by Buchkremer et al. (1997) compared four different,
active combined treatment conditions to a control group. Each active
combined treatment included at least two different treatments:
1) Psychoeducational medication management training and leisure-
time group, 2) Psychoeducational medication management training,
leisure-time group, and family psychoeducation, 3) Psychoeducational
medication management training and cognitive therapy, and
4) Psychoeducational medication management training, cognitive
therapy, and family psychoeducation. The control treatment group
was a leisure-time group alone. To investigate treatment outcomes,
the authors opted to combine the four active treatment groups to com-
pare with the control. They found no significant improvement in nega-
tive symptoms on the SANS for all active treatments combined, and no
significant difference between the combined active treatment group
compared to the control condition at post-treatment or at the 12- and
24-month follow-up.
Finally, Magliano et al. (2006) compared a psychoeducational
family intervention to a waitlist control. The psychoeducational fam-
ily intervention included assessing needs, informational sessions for
people with schizophrenia and their family, as well as communication
and problem-solving skills training. The treatment involved at least
three hourly sessions per month for six months; frequency and loca-
tion of those meetings was individually determined. There was no
significant difference between groups or a significant improvement
on the BPRS negative subscale post-treatment (Magliano et al., 2006).
6.3.3. Combined treatments with SST or CBT
We identified seven studies that combined CBT and/or SST with
at least one other treatment modality (Barrowclough et al., 2001;
Daniels, 1998; Granholm et al., 2005; Hogarty et al., 1991; Palma-
Sevillano et al., 2011; Pinto et al., 1999; Yildiz et al., 2004). Four
of these studies found that the combined treatment approach was
associated with a greater improvement in negative symptoms com-
pared to either TAU; one study found that the combined treatment
and the control treatment (supportive therapy) were associated with
an improvement in negative symptoms, and two did not find any neg-
ative symptom improvements.
An RCT by Hogarty et al. (1991) compared social skills training
alone, family psychoeducation alone, and family psychoeducation
plus social skills training combined to TAU (medication and supportive
therapy) over 24 months. They found that people in both family condi-
tions (family psychoeducation alone and family psychoeducation plus
social skills training) showed an improvement on the social withdrawal
scale of theWingNegative Symptom Scale post-treatment compared to
TAU. Barrowclough et al. (2001) randomly assigned people to either an
Integrated Intervention Program (IIP; consists of motivational therapy,
CBT, and family support) or to TAU (psychiatric management via case
management andmedication,monitoring via outpatient and communi-
ty follow-ups, and access to community-based rehabilitation facilities).
Those who received the combined treatment had improved negative
symptom scores on the PANSS compared to those who received TAU.
However, these improvements were not maintained at the three-
month follow-up.
In another small RCT, Yildiz et al. (2004) compared SST plus family
psychoeducation to TAU. Those who received the combined treatment
met twice a week, and their family attended sessions every two
weeks, while those who received TAU received discussion of treatment
issues and monthly meetings with a psychiatrist. Following treatment,
thosewho received the combined treatment had improvements in neg-
ative symptoms according to the PANSS negative scale compared to
baseline as well as compared to those who received TAU. An RCT com-
pared cognitive motivational therapy to routine care (Palma-Sevillano
et al., 2011). The cognitive motivational therapy was a combination of
psychoeducation, individual CBT, family intervention, and motivational
intervention. Routine care included pharmacological treatment. After
six months of treatment, people who received cognitive motivational
therapy had significantly greater improvement on the PANSS negative
scale compared to people who received routine treatment. Finally,
Pinto et al. (1999) randomly assigned people to individual treatment
of either combined CBT plus SST or to supportive therapy. For people
in the CBT plus SST group, the frequency and duration of therapy
was based on treatment needs. Although people in both treatments
exhibited improvement on the SANS at post-treatment, there were no
significant differences between CBT plus SST compared to supportive
therapy.
Two studies combining either CBT or SST (or both with each other)
did not find improvements in negative symptoms. An RCT by Granholm
et al. (2005) compared a combined group treatment of CBT plus SST to
TAU. People in CBT plus SST group met weekly for two-hour sessions
over the course of 24 weeks. TAU was not standardized across partici-
pants, although 82% reported medication visits and 19% reported
engaging in some type of psychotherapy in the six weeks prior to the
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study. People who received CBT plus SST showed no improvements in
PANSS negative symptoms from pre- to post-treatment and compared
to those who received TAU. Daniels (1998) found no differences in
SANS negative symptom scores post treatment between people ran-
domly assigned to a group that combined social skills and cognitive
behavior techniques (two 50-min. sessions per week over the course
of eight weeks) or to a waitlist control.
6.4. Summary
Studies that combinemore than one treatment have the potential to
elucidate whether individual treatments are efficacious as well as po-
tential additive benefits of combining treatments. To do so, however,
the design must compare the two (or more) treatments individually
to the combination of those treatments. Only two studies specifically
compared the efficacy of combined treatments to the individual
treatments that comprised the combination, rather than comparing
the combination to a TAU or waitlist condition (Hogarty et al.,
1991, 1997) and both found that the combined treatment was asso-
ciated with a greater improvement in negative symptoms. The other
studies compared combination treatment conditions to a control
condition (e.g., TAU, supportive therapy, another combined treat-
ment, or a waitlist condition); thus, it is impossible to interpret
whether the combined treatment approach provides additional ben-
efits above and beyond the benefits of the individual treatment
packages.
Practically speaking, there are reasons to think that family therapy
might help with negative symptoms. By virtue of the fact that the
family is involved in treatment, the person with schizophrenia may
be receiving more social support than in an individual treatment,
and therefore more opportunities to engage in social activities and
behaviors. As such, peoplewith schizophreniamay feelmore connected
and may be better able to develop feelings of social connectedness.
Indeed, the two studies that looked at family therapy alone found an
improvement in negative symptoms (Dyck et al., 2000; Girón et al.,
2010). Furthermore, eight of the eleven studies that included some
type of family component demonstrated an improvement in negative
symptoms. However, it may also be the case that peoplewho have fam-
ilymembers who are willing to be involved in treatmentmay represent
a subgroup of people with schizophrenia who are more amenable to
psychosocial interventions and have a greater support network to assist
with treatment.
Most of the studies (fourteen of the eighteen reviewed here) did
not include follow-up assessments and thus it remains unclear
whether symptom improvements persisted longer-term. One study
with a duration of three years (Hogarty et al., 1997) indicated that
improvements in negative symptoms did not occur until the second
and third year of therapy, while a second study (Petersen et al., 2005;
Thorup et al., 2005) indicated improvements in negative symptoms
at 12 and 24 months; this potentially indicates that longer interven-
tions are needed. Finally, many of the studies that made claims about
negative symptoms in the results utilized outcome measures that
assessed social functioning rather than negative symptoms. Measures
of social functioning do not necessarily capture or indicate improve-
ment in the negative symptoms broadly or in asociality specifically.
Adding psychoeducation does not appear to be associated with
an improvement in negative symptoms, at least in the three studies
that incorporated psychoeducation and assessed negative symptoms
where just one found a reduction in negative symptoms. However,
the impact of psychoeducation specifically on negative symptoms
was not directly tested; psychoeducation was only provided along
with other treatments, and never as a standalone treatment. Thus,
the efficacy of psychoeducation, whether alone or in combination with
other treatments, remains an important avenue for future research.
In sum, despite the fact that two-thirds of the studies reviewed
here indicated improvement in negative symptoms post-treatment,
it is difficult to ascertain whether this can be attributed to the addition
(or combination) of different therapies. Additional research is needed to
first elucidate which of these components are effective, and then test
whether there is an additive effect when combining these components,
and whether these effects persist over time. To address these issues,
researchers should utilize longitudinal designs, test the efficacy of
these treatments in and of themselves as well as in combination with
each other, and include standardized negative symptom rating scales.
7. General discussion
Although psychosocial treatment modalities appear promising for
improving negative symptoms, there are many unanswered questions
about how best to intervene. Of the interventions reviewed, CBT and
SST appear to have the most empirical support. Indeed, two-thirds of
the CBT and nearly three-quarters of SST studies found an improvement
at post-treatment, follow-up or both. However, there are twice asmany
RCTs for CBT as SST (either alone or in combination with another
treatment), and only one of these studies examined an intervention
designed to specifically target negative symptoms. While the com-
bined treatment approach also shows promise, it remains unclear if
combined treatments provide improvements above and beyond
those associated with each individual treatment modality.
Our review suggests preliminarily that CBT and SST may differ in
their efficacy at follow-up. That is, 64% (9/14) of CBT studies that
re-assessed negative symptoms at follow-up (ranging from 3- to
60-month follow-up) reported maintenance of negative symptom
improvement, while 40% (2/5) of SST studies that re-assessed
negative symptoms at follow-up (only a six-month follow-up in
both studies) reported similarly maintained gains. Differences be-
tween the CBT and SST trials may help account for this potential dif-
ference. First, even though the two treatment types did not differ in
average treatment length, the range of treatment lengths differed be-
tween SST (ranging from 9 weeks to 24 months, with a mean of
8.75 months) and CBT (ranging from 2 to 18 months, with a mean
of six months) as did the timing of follow-up assessments. Three of
the five SST studies included a follow-up at either three or six months
post-treatment. In contrast, of the 14 CBT studies that reported on
follow-up data, 13 of them included follow-up from six months to five
years post-treatment, while only two reported on short-term
follow-up at three months. Additional research is needed to examine
whether the duration of treatment is a factor in sustaining a
longer-lasting improvement in negative symptoms.
A second consideration is that CBT and SST differ in structure and
format. Every SST treatment was conducted in a group setting, while
CBT was more often an individual treatment. By providing individuals
with the opportunity to engage socially without expending much ef-
fort to do so (e.g. having a social context provided rather than having
to seek out social situations), it is unclear whether these improve-
ments in social behavior and negative symptoms would extend be-
yond the treatment setting. On the other hand, providing a social
context for treatment may be an “active” ingredient of SST, and peo-
ple with schizophrenia who successfully attend such group treat-
ments may thus benefit by virtue of their joining in with a group of
people. Interestingly, three studies also found that group CBT was at
least partially effective at improving negative symptoms (Bechdolf
et al., 2004; Borras et al., 2009; Drury et al., 1996).
Another difference between CBT and SST is of course the treatment
content. The goal of SST is to improve social functioning through learn-
ing “externalized” skills (e.g., expressive, receptive, and conversation
skills), whereas CBT focuses more on interpreting and responding to in-
ternal experiences (e.g., thoughts and feelings). This difference may
have implications for the continued practice of learned skills and im-
proved outcomes after treatment ends. For example, those who partic-
ipate in SST must continue to involve themselves in social situations in
order to hone the social skills they have learned in treatment. This may
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be difficult for some people with schizophrenia given available social,
financial, or logistical resources. However, in the case of CBT, people
can continue to practice many of these skills without external cues or
resources. Furthermore, CBT theory suggests that change helps tomod-
ify negative core beliefs or schemas about the self, theworld, and others,
which in turn contributes to more long-lasting change (Beck, 2011).
Regardless, differences in treatment content suggest potential mecha-
nisms for change. For example, are thereways to increase the likelihood
of improvement earlier in the course of treatment that in turnmay per-
sist for longer? It would be interesting for future studies to compare
these two interventions, making sure not only to keep the intervention
format consistent across treatment types, but also to include more ex-
tended follow-up data so that long-term benefits can be assessed.
Significant methodological issues must be addressed in future re-
search of combined treatments, and conclusions about their efficacy
or effectiveness cannot be clearly made. At best, the findings suggest
that the addition of family therapy may be beneficial. Although peo-
ple with schizophrenia who enroll in family therapy studies may rep-
resent a specific subset of this population with unique characteristics
(e.g., family support and engagement), they appear to benefit from
added support and external sources of motivation. Of the eleven stud-
ies reviewed that involved family therapy, eight were associated with
an improvement in negative symptoms.
8. Future directions
Given the relative dearth of effective psychosocial treatments for
negative symptoms in schizophrenia, it is not surprising that efforts
to develop new treatments have increased in recent years. Though
these newer treatments have not been as extensively studied, the
preliminary findings are promising.
8.1. New wave of treatments
Several studies have begun to investigate novel psychosocial inter-
ventions, and preliminary evidence suggests that some may be benefi-
cial for improving negative symptoms. However, these interventions
need to undergo a more rigorous evaluation to determine their efficacy
and effectiveness.2
To date, studies of Cognitive Remediation Training (CRT), computer-
based or paper and pencil-based interventions designed to enhance
basic cognitive abilities (e.g., attention, memory) do not seem to be
effective in improving negative symptoms (Dickinson et al., 2009;
Hodge et al., 2010; McGurk, Mueser, DeRosa, & Wolfe, 2009; Wykes et
al., 2007). However, combiningCRTwith a social component (e.g., social
cognition skills, problem-solving, group format) may be helpful for
improving negative symptoms. For example, an RCT of Cognitive
Enhancement Training (CET), a multi-modal interventions including
computer-based training and social skills training, reported that com-
pared to supportive therapy people with early-course schizophrenia
or schizoaffective disorder showed significant improvements in neg-
ative symptoms, as measured by the Wing Negative Symptom Scale
at post-treatment (Eack et al., 2009) and two years later (Eack,
Mesholam-Gately, Greenwald, Hogarty, & Keshavan, in press). Fur-
ther, an RCT of problem solving and Cognitive Flexibility Training
(Farreny et al., 2012), which is a group treatment targeting cognitive
abilities and general functioning, reported that people who completed
32 group sessions showed greater improvement in PANSS negative
symptom scores than people who completed a leisure control group
(e.g., card games, board games, “coffee & talk”).
We found two small, uncontrolled studies of interventions that
were explicitly designed to target negative symptoms. First, Favrod,
Giuliani, Ernst, and Bonsack (2010) found that after 10–25 h of
Cognitive-Sensory Training (CST), a skills-based intervention to di-
rectly target deficits in anticipatory pleasure and anhedonia, there
was a significant improvement on the anticipatory pleasure subscale
of the Temporal Experience of Pleasure Scale (Gard et al., 2007), as
well as an increase in both the number and complexity of activities
in which people participated, suggesting that this intervention not
only improved anticipatory pleasure deficits, but that these im-
provements were also associated with increased functioning. Second,
an open trial of Loving Kindness Meditation (LKM), an intervention
that teaches skills in concentrationmeditation and focuses onmindfully
directing compassion and warmth toward the self and others as a
tool for increasing positive emotions and resources, found that peo-
ple with schizophrenia reported an increase in positive emotions,
self-acceptance, satisfaction with life, and an improvement in nega-
tive symptoms after participating in six meditation sessions, and
these benefits remained at a three-month follow-up (Johnson et al.,
2011), suggesting that interventions focused on increasing personal
resources and well-being may help to improve negative symptoms.
8.2. Standardization of study measurement and design
What has become clear from the current review is the need for
standardization in negative symptom assessment, treatment imple-
mentation, and follow-up time points, as well as replication of inter-
ventions that have shown efficacy in improving negative symptoms.
First, more than half of the initial studies identified for this review
did not report on negative symptoms, and thus future studies should
include and report assessments of negative symptoms in order to fur-
ther assess whether a psychosocial treatment is helpful for these
symptoms. Of the studies that did report on negative symptoms, the
lack of a standard negative symptom measure(s) makes it difficult
to draw conclusions about efficacy across studies. Further, the most
widely used measures of negative symptomatology (PANSS and SANS)
include items that are not considered to be part of the negative symp-
toms construct (e.g., attentional impairment, difficulty in abstract think-
ing, stereotyped thinking) and rely more heavily on behavioral aspects
of negative symptoms (e.g. blunted affect, social activity), placing less
emphasis on experiential or motivational components (e.g. internal de-
sire or experienced emotion). This is problematic because behavioral
deficits may result from factors unrelated to negative symptoms,
including financial or social constraints. Furthermore, while deficits in
behavior may exist (e.g., blunted affect, decreased social interactions,
decreased speech production), internal experiences may remain intact
(e.g., desire to be around family, interest in recreational activities,
pleasure from interacting with others). Thus, ratings gained from
current negative symptom assessments that rely heavily on behavior
may result in elevated negative symptom scores in instances where
these scores are not warranted because internal experiences are
not considered (Blanchard, Kring, Horan, & Gur, 2011; Horan et al.,
2011). Using negative symptom assessments that measure each of
the five agreed upon symptom domains and systematically measures
experience and behavior, such as the Clinical Assessment Interview
for Negative Symptoms (Kring et al., 2013) or the Brief Negative
Symptom Scale (Kirkpatrick et al., 2011), will provide a more com-
prehensive measure of negative symptoms.
Second, in order to compare, learn from, and improve treatments
for negative symptoms, it is necessary to replicate previous findings
using the same manualized treatment and to standardize the method
of implementation of these interventions (e.g., number of sessions,
length of sessions, group vs. individual sessions, content discussed,
etc.). Of course, these aspects may differ based on the type of treatment,
2 Other treatments that have assessed negative symptom outcomes but with only 1
or 2 RCTs include, art therapy (Crawford et al., 2012; Richardson, Jones, Evans, & Rowe,
2007), music therapy (Ulrich, Houtmans, & Gold, 2007), dance therapy (Rohricht &
Priebe, 2006), occupational therapy (Cook, Chambers, & Coleman, 2009), vocational re-
habilitation (Bio & Gattaz, 2011), and dog-assisted group integrated psychological
therapy (Villalta-Gil et al., 2009).
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but it is difficult to compare the efficacy of any treatmentmodality given
the huge variation in treatment protocols. If manualized treatments
are used, studies should measure and report treatment fidelity in order
to monitor, enhance, and ensure the accurate administration of the
intervention. Unfortunately, only 22 of the 46 studies included in
this review did so, and measures of treatment fidelity varied across
studies (e.g., adherence checklists, sessions coded by raters, etc.).
There is also a need to assess which components of various treat-
ments are useful and for whom. If treatments are combined, studies
should include groups with random assignment to the individual
treatment components alone in order to determine if the combined
approach provides additional benefits. There is also variation in the
definition of TAU across studies, making improvement or the lack
thereof difficult to interpret across studies. Finally, it may also be
the case that existing psychosocial treatments be further adapted
so as to take into account cognitive deficits, at least with those people
who havemore severe deficits. In other words, some treatments may
need to be simplified, longer in duration, and include greater repeti-
tion of treatment modules.
Third, future studies should include common follow-up assessment
time-points and track the continued use of therapy skills across time.
As discussed, it is necessary for treatment trials to include follow-up
assessments at least 12 months post-treatment and longer in order to
track longer-term outcomes. Furthermore, tracking the use of therapy
skills, both during treatment and after treatment is completed, will pro-
vide additional insight into whether continued practice is necessary
to maintain outcomes. The ability to measure, report, and compare the
practice of treatment skills may help to explain differences in short-
term and long-term outcomes across treatment modalities and provide
evidence for the practical application of these interventions in a commu-
nity setting. That is, if continued practice of skills is necessary to see
change, but consumers are unlikely to engage in these behaviors, is the
treatment feasible and beneficial?
Finally, even when statistically significant changes in negative
symptoms are reported, this information provides little insight into
individualized improvement. Thus, future studies should include clin-
ically meaningful change as an outcome measure (Jacobson & Truax,
1991). In order to include measures of clinically significant change,
studies must define clinical change a priori and report these outcomes
in addition to statistical change. Only seven studies included in our
review reported clinically significant change metrics for negative
symptoms (all investigating CBT),with four finding clinically significant
change (Lincoln et al., 2012; Startup et al., 2004; Turkington, Kingdon,
et al., 2006; Turkington et al., 2008) and three finding no clinically
significant change (Bechdolf et al., 2004; Lecomte et al., 2008; Tarrier
et al., 1993).
8.3. Additional considerations in treatment development
Although motivation for change is a common a barrier to treatment
across psychological disorders and treatment modalities, deficits in
motivated behavior are part of the negative symptom construct and
may make it particularly challenging for people with negative symp-
toms to engage in treatment. That is, the very people we are designing
treatments for may never make it to our office because the symptoms
we are trying to improve may be a barrier to treatment engagement.
Yet, over three-quarters of studies reviewed here reported dropout
rates of 20% or lower, suggesting that after the initial hurdle of begin-
ning treatment people with schizophrenia and negative symptoms are
able to persist in treatment. Future studies should continue to report
on dropout rates in order to more systematically evaluate the extent
to which avolition is a treatment barrier.
Little is known about how comorbid disorders (e.g., anxiety, de-
pression, substance use) may further complicate interventions for
negatives symptoms (as in Barrowclough et al., 2001). For example,
if a person has social anxiety, group treatments may be avoided, not
because of lack of motivation, but because of discomfort around
others. Thus, common comorbid conditions that may present a poten-
tial treatment barrier should be assessed and reported in order to
determine if these treatments are ineffective because they are not
helpful for negative symptoms or because other conditions or symp-
toms prevent the person for engaging and benefitting from treat-
ment. If the latter is the case, we may unjustly rule out potentially
beneficial negative symptom treatments.
Furthermore, there are likely groups and subgroups for which var-
ious treatment components will work to greater or lesser extents.
While including people with complex or comorbid disorders may bet-
ter represent people seeking services from community mental health
centers, efficacy studies should report on outcomes between diagnos-
tic and symptom groups to discover which treatments work best for
which subgroups. After initial efficacy for a treatment approach is
established, future studies should extend the treatment to examine
its effectiveness in a community sample. Finally, as future directions
become current directions, it is also necessary to find better ways of
disseminating these findings, assessment measures, and treatments
to the broader community of researchers, clinicians, support persons
and family, as well as to those people with schizophrenia.
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